Differences in survival of melanoma patients after immune checkpoint inhibitor discontinuation for response or toxicity - a single center analysis by patient sex
Authors
Isabelle Aschwanden
AbbVie AG
Presenter
Ferdinando Cerciello
Department of Medical Oncology, Inselspital, Bern University Hospital
Christoph Oliver Ryser
Ruben Bill
Department of Medical Oncology, Inselspital, Bern University Hospital
Katrin Gysel
Swiss Group for Clinical Cancer Research (SAKK) Competence Center